SAHPRA and Zimbabwe Medicines Control Authority sign MoU

The MoU between SAHPRA and MCAZ will allow both regulators to develop a cooperative partnership towards ensuring access to safe, quality and effective health products in South African and Zimbabwe. 

Two people shaking hands as part of an agreement (Image: Unsplash)

SAHPRA, the South African Health Products Regulatory Authority, has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ). 

Both entities will cooperate on joint products reviews and inspections to enable efficient access to health products. This partnership will also focus on detection and curbing of substandard and falsified health products moving between the two countries, which has off late been a major challenge that the two regulators have identified. 

Capacity building on the African continent

“The forging of partnerships such as this MoU with the Medicines Control Authority of Zimbabwe, a fellow African National Regulatory Authority, is key to further enhancing and building capacity on the continent”, indicates SAHPRA CEO, Dr Boitumelo Semete-Makokotlela. 

“This landmark event marks a significant step towards strengthening the regulatory frameworks of both Zimbabwe and South Africa in the pharmaceutical sector. The MoU is designed to facilitate cooperation and collaboration between the two countries in the areas of medicines regulation, quality control, and pharmacovigilance”, shares MCAZ Director-General, Mr Richard Rukwata. 

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za